Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Madsbad

Showing results (161-170 of 223) with videos related to

Pageof 23
Sort By:
The Journal of Clinical Endocrinology and Metabolism|June 1, 1983
Diminished immunoreactive gastric inhibitory polypeptide response to a meal in newly diagnosed type I (insulin-dependent) diabeticsT Krarup, S Madsbad, A J Moody, et al.
European Journal of Clinical Investigation|May 11, 2006
Hyperproinsulinaemia in normoglycaemic lipodystrophic HIV-infected patientsS B Haugaard, O Andersen, C N Hales, et al.
Diabetes, Obesity & Metabolism|April 13, 2010
Twelve weeks treatment with the DPP-4 inhibitor, sitagliptin, prevents degradation of peptide YY and improves glucose and non-glucose induced insulin secretion in patients with type 2 diabetes mellitusK Aaboe, F K Knop, T Vilsbøll, et al.
The New England Journal of Medicine|August 13, 1987
Metabolic and cardiovascular responses to epinephrine in diabetic autonomic neuropathyJ Hilsted, E Richter, S Madsbad, et al.
Diabetologia|January 31, 2012
Steroid-induced insulin resistance and impaired glucose tolerance are both associated with a progressive decline of incretin effect in first-degree relatives of patients with type 2 diabetesD H Jensen, K Aaboe, J E Henriksen, et al.
Acta Medica Scandinavica|January 1, 1981
Very early changes in circulating T3 and rT3 during development of metabolic derangement in diabetic patientsS Madsbad, P Laurberg, J Weeke, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|November 5, 2003
Preanalytical handling of samples for measurement of plasma lactate in HIV patientsO Andersen, S B Haugaard, L T Jørgensen, et al.
European Journal of Clinical Investigation|September 1, 2005
Plasminogen activator inhibitor type 1 (PAI-1) in plasma and adipose tissue in HIV-associated lipodystrophy syndrome. Implications of adipokinesG He, O Andersen, S B Haugaard, et al.
British Medical Journal|November 17, 1979
Role of residual insulin secretion in protecting against ketoacidosis in insulin-dependent diabetesS Madsbad, K G Alberti, C Binder, et al.
Diabetologia|July 1, 1993
On the effects of human galanin in manJ J Holst, M Bersani, A Hvidberg, et al.
Pageof 23

Showing results (161-170 of 223) with videos related to

Sort By:
Pageof 23
The Journal of Clinical Endocrinology and Metabolism|June 1, 1983
Diminished immunoreactive gastric inhibitory polypeptide response to a meal in newly diagnosed type I (insulin-dependent) diabeticsT Krarup, S Madsbad, A J Moody, et al.
European Journal of Clinical Investigation|May 11, 2006
Hyperproinsulinaemia in normoglycaemic lipodystrophic HIV-infected patientsS B Haugaard, O Andersen, C N Hales, et al.
Diabetes, Obesity & Metabolism|April 13, 2010
Twelve weeks treatment with the DPP-4 inhibitor, sitagliptin, prevents degradation of peptide YY and improves glucose and non-glucose induced insulin secretion in patients with type 2 diabetes mellitusK Aaboe, F K Knop, T Vilsbøll, et al.
The New England Journal of Medicine|August 13, 1987
Metabolic and cardiovascular responses to epinephrine in diabetic autonomic neuropathyJ Hilsted, E Richter, S Madsbad, et al.
Diabetologia|January 31, 2012
Steroid-induced insulin resistance and impaired glucose tolerance are both associated with a progressive decline of incretin effect in first-degree relatives of patients with type 2 diabetesD H Jensen, K Aaboe, J E Henriksen, et al.
Acta Medica Scandinavica|January 1, 1981
Very early changes in circulating T3 and rT3 during development of metabolic derangement in diabetic patientsS Madsbad, P Laurberg, J Weeke, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|November 5, 2003
Preanalytical handling of samples for measurement of plasma lactate in HIV patientsO Andersen, S B Haugaard, L T Jørgensen, et al.
European Journal of Clinical Investigation|September 1, 2005
Plasminogen activator inhibitor type 1 (PAI-1) in plasma and adipose tissue in HIV-associated lipodystrophy syndrome. Implications of adipokinesG He, O Andersen, S B Haugaard, et al.
British Medical Journal|November 17, 1979
Role of residual insulin secretion in protecting against ketoacidosis in insulin-dependent diabetesS Madsbad, K G Alberti, C Binder, et al.
Diabetologia|July 1, 1993
On the effects of human galanin in manJ J Holst, M Bersani, A Hvidberg, et al.
Pageof 23